0527-1947 : Lopinavir-ritonavir Oral Solution
NDC: | 0527-1947 |
Labeler: | Lannett Company, Inc. |
Product Type: | Human Prescription Drug |
Drug Name: | Lopinavir-ritonavir |
Dosage Form: | Oral Solution |
Application #: | ANDA207407 |
Rev. Date: |
NDC Package Codes:
- 0527-1947-48: 1 BOTTLE, PLASTIC IN 1 CARTON (0527‑1947‑48) > 160 ML IN 1 BOTTLE, PLASTIC
Active Ingredients:
- Lopinavir
- Ritonavir
Dosage Strength:
- 80 mg/mL
- 20 mg/mL
Pharmaceutical Classes:
- HIV Protease Inhibitors [MoA]
- Protease Inhibitor [EPC]
- P-Glycoprotein Inhibitors [MoA]
- Cytochrome P450 3A Inhibitors [MoA]
- Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA]
- Cytochrome P450 3A Inhibitor [EPC]
- Cytochrome P450 2D6 Inhibitors [MoA]
- Cytochrome P450 2C19 Inducers [MoA]
- Cytochrome P450 3A Inducers [MoA]
- Breast Cancer Resistance Protein Inhibitors [MoA]
- Cytochrome P450 3A4 Inhibitors [MoA]
- Cytochrome P450 1A2 Inducers [MoA]
- Cytochrome P450 2C9 Inducers [MoA]
- Cytochrome P450 2B6 Inducers [MoA]
- UDP Glucuronosyltransferases Inducers [MoA]
NDC QR Code
Scan the QR code below to easily reference this data in the future:< Prev: 0527-1943Next: 0527-1948 >
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.